Hopital Universitaire Hautepierre Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1997
NCT00003031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Anesthesia, Critical Care & Perioperative Medicine, Hautepierre, Strasbourg, France

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aspergillosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3